Suppression of myasthenia gravis by antigen-specific mucosal tolerance and modulation of cytokines and costimulatory factors

Keyphrases

• Myasthenia Gravis 100%
• Experimental Autoimmune Myasthenia Gravis 100%
• Costimulatory Molecules 100%
• Antigen-specific 100%
• Cytokine Factors 100%
• Mucosal Tolerance 100%
• Recombinant Fragment 60%
• Acetylcholine Receptor (AChR) 40%
• Acetylcholine Receptor Subunit 40%
• Syngeneic 40%
• Mucosal Administration 40%
• Xenogeneic 40%
• Severely Affected 20%
• Interleukin-18 (IL-18) 20%
• Myasthenic 20%
• Myasthenia 20%
• Synthetic Peptides 20%
• Alleviation 20%
• Chronic Phase 20%
• Specific Immunotherapy 20%
• Cytokine Profile 20%
• Clinical Symptoms 20%
• CD40 Ligand (CD40L) 20%
• Recombinant 20%
• Inflammatory Cytokines 20%
• Extracellular Region 20%
• Direct Modulation 20%

Immunology and Microbiology

• Experimental Autoimmune Myasthenia Gravis 100%
• Myasthenia gravis 100%
• Cytokine 100%
• Antigen Specificity 100%
• Syngenic 40%
• Monospecific Antibody 20%
• Interleukin 18 20%
• Downregulation 20%
• CD40 Ligand 20%
• Proinflammatory Cytokine 20%

Biochemistry, Genetics and Molecular Biology

• Acetylcholine Receptor 100%
• Antigen Specificity 100%
• Cytokine 100%
• Syngenic 50%
• Downregulation 25%
• Monospecific Antibody 25%
• Interleukin 18 25%
• Proinflammatory Cytokine 25%